J. Wu

First name
Last name
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Mamas, M. A., et al. (2022). Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3ยท4 million individuals. Lancet Reg Health Eur, 17, 100386. http://doi.org/10.1016/j.lanepe.2022.100386
Wu, J., Mackie, S. L., & Pujades-Rodriguez, M. (2020). Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2020-001220
Pujades-Rodriguez, M., Morgan, A. W., Cubbon, R. M., & Wu, J. (2020). Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Med. http://doi.org/10.1371/journal.pmed.1003432
Nadarajah, R., Wu, J., Frangi, A. F., Hogg, D., Cowan, C., & Gale, C. (2021). Predicting patient-level new-onset atrial fibrillation from population-based nationwide electronic health records: protocol of FIND-AF for developing a precision medicine prediction model using artificial intelligence. BMJ Open. http://doi.org/10.1136/bmjopen-2021-052887